Quantitative Analysis of Interstitial Lung Disease via AI-Enhanced Chest CT in Patients with Idiopathic Inflammatory Myopathies: Correlation with Expert Visual Evaluation in 107 Cases - Summary - MDSpire
Advertisement
Quantitative Analysis of Interstitial Lung Disease via AI-Enhanced Chest CT in Patients with Idiopathic Inflammatory Myopathies: Correlation with Expert Visual Evaluation in 107 Cases
To compare a commercially available AI-based chest HRCT analysis tool with semi-quantitative visual scoring by an experienced thoracic radiologist for quantifying ILD lesions in patients with IIM-associated ILD, highlighting the potential for improved diagnostic accuracy.
Visual scoring by radiologists showed variability, particularly for subtle changes, indicating a need for standardized assessment.
AI metrics correlated with disease severity and functional impairment, suggesting their utility in clinical monitoring.
Interpretation:
AI-enhanced HRCT analysis may improve the objectivity and reproducibility of ILD assessment in IIM patients, potentially aiding in clinical decision-making.
Limitations:
Study conducted at a single center, limiting generalizability and introducing potential selection bias.
Small sample size may affect the robustness of findings.
Variability in HRCT acquisition techniques among patients may influence results.
Conclusion:
AI-based HRCT analysis shows promise for quantifying ILD in IIM patients, potentially serving as a reliable imaging biomarker that could enhance clinical decision-making and patient management.
